127 related articles for article (PubMed ID: 34597998)
21.
Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX
Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689
[TBL] [Abstract][Full Text] [Related]
22. IL-33 contributes to disease severity in Psoriasis-like models of mouse.
Duan Y; Dong Y; Hu H; Wang Q; Guo S; Fu D; Song X; Kalvakolanu DV; Tian Z
Cytokine; 2019 Jul; 119():159-167. PubMed ID: 30913451
[TBL] [Abstract][Full Text] [Related]
23. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
[TBL] [Abstract][Full Text] [Related]
24. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
[TBL] [Abstract][Full Text] [Related]
25. Acetyl-11-keto-β-boswellic acid inhibits the secretion of cytokines by dendritic cells via the TLR7/8 pathway in an imiquimod-induced psoriasis mouse model and in vitro.
Wang MX; Zhao JX; Meng YJ; Di TT; Xu XL; Xie XJ; Lin Y; Zhang L; Wang N; Li P; Wang Y
Life Sci; 2018 Aug; 207():90-104. PubMed ID: 29859222
[TBL] [Abstract][Full Text] [Related]
26. Increased βTrCP are associated with imiquimod-induced psoriasis-like skin inflammation in mice via NF-κB signaling pathway.
Li R; Wang J; Wang X; Zhou J; Wang M; Ma H; Xiao S
Gene; 2016 Oct; 592(1):164-171. PubMed ID: 27476970
[TBL] [Abstract][Full Text] [Related]
27. PDRN, a Bioactive Natural Compound, Ameliorates Imiquimod-Induced Psoriasis through NF-κB Pathway Inhibition and Wnt/β-Catenin Signaling Modulation.
Irrera N; Bitto A; Vaccaro M; Mannino F; Squadrito V; Pallio G; Arcoraci V; Minutoli L; Ieni A; Lentini M; Altavilla D; Squadrito F
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059361
[TBL] [Abstract][Full Text] [Related]
28. Rosmarinic acid protects mice from imiquimod induced psoriasis-like skin lesions by inhibiting the IL-23/Th17 axis via regulating Jak2/Stat3 signaling pathway.
Zhang M; Li N; Cai R; Gu J; Xie F; Wei H; Lu C; Wu D
Phytother Res; 2021 Aug; 35(8):4526-4537. PubMed ID: 34008239
[TBL] [Abstract][Full Text] [Related]
29. Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-α/IFN-γ-induced inflammatory response in keratinocytes and T cell-derived IL-17.
Lin ZM; Ma M; Li H; Qi Q; Liu YT; Yan YX; Shen YF; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP
Pharmacol Res; 2018 Mar; 129():443-452. PubMed ID: 29155016
[TBL] [Abstract][Full Text] [Related]
30. The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimod-induced murine model.
Wu S; Zhao M; Sun Y; Xie M; Le K; Xu M; Huang C
Life Sci; 2020 Jan; 241():117115. PubMed ID: 31790685
[TBL] [Abstract][Full Text] [Related]
31. Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis.
Qin S; Wen J; Bai XC; Chen TY; Zheng RC; Zhou GB; Ma J; Feng JY; Zhong BL; Li YM
Mol Med Rep; 2014 Jun; 9(6):2097-104. PubMed ID: 24718773
[TBL] [Abstract][Full Text] [Related]
32. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice.
Sun J; Zhao Y; Hu J
PLoS One; 2013; 8(6):e67078. PubMed ID: 23825622
[TBL] [Abstract][Full Text] [Related]
33. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
[TBL] [Abstract][Full Text] [Related]
34. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin.
Varma SR; Sivaprakasam TO; Mishra A; Prabhu S; M R; P R
Eur J Pharmacol; 2017 Oct; 813():33-41. PubMed ID: 28736282
[TBL] [Abstract][Full Text] [Related]
35. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells.
Yoshiki R; Kabashima K; Honda T; Nakamizo S; Sawada Y; Sugita K; Yoshioka H; Ohmori S; Malissen B; Tokura Y; Nakamura M
J Invest Dermatol; 2014 Jul; 134(7):1912-1921. PubMed ID: 24569709
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice.
Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; As Sobeai HM; Alotaibi MR
Biochimie; 2020 Dec; 179():146-156. PubMed ID: 33007409
[TBL] [Abstract][Full Text] [Related]
37. Topical Sunitinib ointment alleviates Psoriasis-like inflammation by inhibiting the proliferation and apoptosis of keratinocytes.
Kuang YH; Lu Y; Liu YK; Liao LQ; Zhou XC; Qin QS; Jia XK; Wu LS; Zhu W; Chen X
Eur J Pharmacol; 2018 Apr; 824():57-63. PubMed ID: 29382533
[TBL] [Abstract][Full Text] [Related]
38. 310 nm UV-LEDs attenuate imiquimod-induced psoriasis-like skin lesions in C57BL/6 mice and inhibit IL-22-induced STAT3 expression in HaCaT cells.
Kwon TR; Lee SE; Kim JH; Na Jang Y; Kim SY; Mun SK; Kim CW; Na J; Kim BJ
Photochem Photobiol Sci; 2020 Aug; 19(8):1009-1021. PubMed ID: 32584352
[TBL] [Abstract][Full Text] [Related]
39. Amentoflavone protects against psoriasis-like skin lesion through suppression of NF-κB-mediated inflammation and keratinocyte proliferation.
An J; Li Z; Dong Y; Ren J; Huo J
Mol Cell Biochem; 2016 Feb; 413(1-2):87-95. PubMed ID: 26724949
[TBL] [Abstract][Full Text] [Related]
40. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
Morimura S; Oka T; Sugaya M; Sato S
J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
